Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic

Hum Vaccin Immunother. 2022 Nov 30;18(6):2095823. doi: 10.1080/21645515.2022.2095823. Epub 2022 Jul 11.

Abstract

The COVID-19 pandemic has had a dramatic impact on society, but little is known about how the pandemic affects the vaccine policy landscape and public perception of vaccines in Thailand. This study aims to describe potential changes in Thailand's policy landscape post-pandemic. We performed a literature review and in-depth interviews with 12 key informants to understand the policy landscape in Thailand. The findings were shared in a policy forum in December 2021. Several key findings were summarized. Funding and development have been thriving during the pandemic. However, a long-term commitment from all stakeholders is required to maintain policy continuation. A public-private partnership should be considered. The regulatory body needs to be prepared for product authorization. The vaccine introduction decision-making process, and investment in prevention and promotion, should further be discussed. In summary, it is important to reshape the environment and mentality of all stakeholders to create a sustainable and self-sufficient vaccine ecosystem.

Keywords: COVID-19; Vaccine; health policy.

Publication types

  • Review

MeSH terms

  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Ecosystem
  • Health Policy
  • Humans
  • Pandemics / prevention & control
  • Thailand / epidemiology
  • Vaccines*

Substances

  • Vaccines

Grants and funding

We receive an educational unrestricted grant from Janssen-Cilag Ltd., Thailand. The funder does not have any influence in any step of the research.